World's Best Scientists 2026 revealed!
Award Badge
Medicine
Australia
2023

D-Index & Metrics

Medicine

D-Index
91
Citations
59660
World Ranking
11490
National Ranking
1091

Research.com Recognitions

  • 2023 - Research.com Medicine in Australia Leader Award

Overview

Richard Gray is affiliated with the University of Oxford in the United Kingdom and has a research focus primarily in Medicine, with particular expertise in Oncology, Neurology, and Artificial Intelligence applications in healthcare. Their work encompasses a variety of subfields including Cancer Research and Pulmonary and Respiratory Medicine.

The scientist has contributed extensively to topics such as:

  • Breast Cancer Treatment Studies
  • Colorectal Cancer Surgical Treatments
  • Colorectal Cancer Treatments and Studies
  • AI in cancer detection
  • Genetic factors in colorectal cancer
  • Parkinson's Disease Mechanisms and Treatments
  • Dementia and Cognitive Impairment Research

Richard Gray has published multiple recent papers including:

  • Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT), 2020, The Lancet
  • Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial, 2023, Journal of Clinical Oncology
  • Clinical-Grade Detection of Microsatellite Instability in Colorectal Tumors by Deep Learning, 2020, Gastroenterology
  • Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy, 2021, The Lancet
  • Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study, 2023, Cancer Cell

The frequent co-authors working with Richard Gray include:

  • Rosie Bradley (14 joint publications)
  • Philip Quirke (13 joint publications)
  • Nicholas P. West (12 joint publications)
  • Robert K. Hills (11 joint publications)
  • Jeremy Braybrooke (10 joint publications)

Key publication venues where Richard Gray's research appears frequently are:

  • Journal of Clinical Oncology (6 publications)
  • The Lancet (5 publications)
  • JAMA Neurology (5 publications)
  • Cancer Research (4 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (2 publications)

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

    R Altman;L Carreras;R Diaz;E Figueroa

  • Tamoxifen for early breast cancer: An overview of the randomised trials

    M Clarke;R Collins;C Davies

  • Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.

    M Clarke;R Collins;S Darby;C Davies

  • Systematic review of levodopa dose equivalency reporting in Parkinson's disease

    Claire L. Tomlinson;Rebecca Stowe;Smitaa Patel;Caroline Rick

  • Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials

    S Darby;P McGale;C Correa

  • Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

    C Davies;J Godwin;Richard Gray

  • Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

    C Focan;SM Steinberg;M Blichert-Toft;JF Forbes

  • Polychemotherapy for early breast cancer: an overview of the randomised trials

    M Clarke;R Collins;C Davies

  • Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

    Christina Davies;Hongchao Pan;Jon Godwin;Richard Gray

  • Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.

    R Peto;C Davies;J Godwin

  • Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

    Richard Gray;Jennifer Barnwell;Christopher McConkey

  • Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials

    P McGale;C. Taylor;C Correa

  • Randomised trial of prophylactic daily aspirin in British male doctors

    R Peto;R Gray;R Collins;K Wheatley

  • Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women

    M Clarke;R Collins;J Godwin

  • 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.

    Hongchao Pan;Richard Gray;Jeremy Braybrooke;Christina Davies

  • Revascularization versus medical therapy for renal-artery stenosis.

    K Wheatley;N Ives;R Gray

  • Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials

    M Clarke;R Collins;C Davies

  • EFFECTS OF RADIOTHERAPY AND SURGERY IN EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS

    M Clarke;R Collins;C Davies

  • Mortality inrelation tosmoking: 40years' observations onmale British doctors

    Richard Doll;Richard Peto;Keith Wheatley;Richard Gray

Frequent Co-Authors

Richard Peto
Richard Peto University of Oxford
Keith Wheatley
Keith Wheatley University of Birmingham
Robert Kerrin Hills
Robert Kerrin Hills University of Oxford
David J. Kerr
David J. Kerr University of Oxford
Amylou C. Dueck
Amylou C. Dueck Mayo Clinic
Mike Clarke
Mike Clarke Queen's University Belfast
Carl E Clarke
Carl E Clarke University of Birmingham
Philip Quirke
Philip Quirke University of Leeds
Rory Collins
Rory Collins University of Oxford
Matthew P. Goetz
Matthew P. Goetz Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are exploring alternative or complementary healthcare careers, there are a range of related online degrees and pathways that offer flexible options. For those interested in hands-on patient care, direct entry nursing programs are an accessible choice. These programs often welcome students from diverse backgrounds and can fast-track your journey to becoming a registered nurse.

Aspiring nurses can also consider nursing schools that don't require teas or hesi, which can simplify the admissions process for those deterred by standardized testing.

For learners interested in administrative or technical roles, consider online training for in-demand skills. Accredited medical billing and coding schools online prepare graduates for essential roles in healthcare documentation and insurance.

If you aspire to leadership, a degree in healthcare administration can open doors to managing hospitals, clinics, and health systems. Online programs offer flexibility and support for working adults or career changers.

Best Scientists Citing Richard Gray

Trending Scientists

Recently Published Articles